IRIX IRIDEX Corporation
Healthcare$1.04+2.97%ClosedMarket Cap: $18.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.69
P/S
0.33
EV/EBITDA
-10.07
DCF Value
$-6.72
FCF Yield
-13.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.1%
Operating Margin
-5.1%
Net Margin
-6.2%
ROE
-64.2%
ROA
-11.6%
ROIC
-17.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $11.8M | 40.2% | $-324.0K | $-524.0K | $— | — |
| Q4 null | $14.7M | 38.3% | $-15.0K | $-184.0K | $— | — |
| FY null | $52.7M | 36.7% | $-2.6M | $-4.4M | $— | — |
| Q3 null | $12.5M | 32.1% | $-1.4M | $-1.6M | $— | — |
| Q2 null | $13.6M | 33.9% | $-940.0K | $-994.0K | $— | — |
| Q1 null | $11.9M | 42.5% | $-205.0K | $-1.7M | $— | — |
| Q4 null | $12.7M | 44.0% | $-502.0K | $-834.0K | $— | — |
| FY null | $48.7M | 40.1% | $-8.3M | $-8.9M | $— | — |
| Q3 null | $11.6M | 37.3% | $-1.9M | $-1.9M | $— | — |
| Q2 null | $12.6M | 40.7% | $-2.6M | $-2.7M | $— | — |
| Q1 null | $11.8M | 37.2% | $-3.3M | $-3.5M | $— | — |
| Q4 2023 | $12.5M | 38.6% | $-3.1M | $-3.0M | $-0.18 | — |